To evaluate the expression of the membrane protein CD63 in human CAFs, we reviewed publicly available scRNA‐seq data from human primary breast cancer and found that CAFs infiltrating ERα‐negative breast cancer tissue showed significantly higher CD63 expression than those infiltrating ERα‐positive breast cancer tissue (Figure 3D). This evidence concerns the gene CD63 and breast cancer.